CRESTWOOD ADVISORS GROUP LLC – Ultragenyx Pharmaceutical Inc. Transaction History
CRESTWOOD ADVISORS GROUP LLC portfolio value:
$1.23M
portfolio value
CRESTWOOD ADVISORS GROUP LLC quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | -546K | $41.41 | 29.90K | |
Q2 2022 | share | 0.00% | 0 shares | -388K | $59.66 | 29.90K | |
Q1 2022 | share | 0.00% | 0 shares | -343K | $72.62 | 29.90K | |
Q4 2021 | share | 0.00% | 0 shares | -182K | $84.25 | 29.90K | |
Q3 2021 | share | 0.00% | 0 shares | -155K | $90.19 | 29.90K | |
Q2 2021 | share | 0.00% | 0 shares | -553K | $95.35 | 29.90K | |
Q1 2021 | share | Decrease | -3.55% | -1.1K shares | -887K | $113.86 | 29.90K |
Q4 2020 | share | 0.00% | 0 shares | 1.74M | $138.43 | 31.00K | |
Q3 2020 | share | Decrease | -3.43% | -1.1K shares | 38K | $82.19 | 31.00K |
Q2 2020 | share | Decrease | -3.02% | -1K shares | 1.04M | $78.22 | 32.10K |
Q1 2020 | share | Increase | +1.22% | 400 shares | 74K | $44.43 | 33.10K |
Q4 2019 | share | Decrease | -0.76% | -250 shares | -13K | $42.71 | 32.70K |
Q3 2019 | share | Increase | +0.76% | 250 shares | -667K | $42.78 | 32.95K |
Q2 2019 | share | 0.00% | 0 shares | -192K | $63.5 | 32.70K | |
Q1 2019 | share | 0.00% | 0 shares | 847K | $69.36 | 32.70K | |
Q4 2018 | share | Decrease | -1.51% | -500 shares | -1.11M | $43.48 | 32.70K |
Q3 2018 | share | 0.00% | 0 shares | -5K | $76.34 | 33.20K | |
Q2 2018 | share | Increase | +52.98% | 11.5K shares | 1.43M | $76.87 | 33.20K |
Q1 2018 | share | Increase | +2.36% | 500 shares | 123K | $50.99 | 21.70K |
Q4 2017 | share | 0.00% | 0 shares | -146K | $46.38 | 21.20K | |
Q3 2017 | share | 0.00% | 0 shares | -291K | $53.26 | 21.20K | |
Q2 2017 | share | 0.00% | 0 shares | 127K | $62.11 | 21.20K | |
Q1 2017 | share | Increase | 0.00% | 21.20K shares | 1.29M | $67.78 | 21.20K |